Oncotelic Therapeutics, Inc. (OTLC) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 24 transactions totaling $65.9K, demonstrating a bullish sentiment with $65.9K in net insider flow. The most recent transaction on Jan 22, 2026 involved a transaction of 4,426 shares valued at $0.
No significant insider buying has been recorded for OTLC in the recent period.
No significant insider selling has been recorded for OTLC in the recent period.
Based on recent SEC filings, insider sentiment for OTLC is bullish with an Insider Alignment Score of 100/100 and a net flow of $65.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Oncotelic Therapeutics, Inc. (OTLC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading OTLC stock, having executed 24 transactions in the past 90 days. The most active insider is Vuong Trieu (Executive), who has made 19 transactions totaling $65.9K.
Get notified when executives and directors at OTLC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Trieu Vuong | Executive | Award | 4,426 | $N/A | $0 | |
| Jul 10, 2025 | Trieu Vuong | Executive | Purchase | 104,000 | $0.01 | $1.0K | |
| Jul 9, 2025 | Trieu Vuong | Executive | Purchase | 1 | $0.01 | $0 | |
| Jul 8, 2025 | Trieu Vuong | Executive | Purchase | 94,736 | $0.01 | $947 | |
| Aug 23, 2024 | Trieu Vuong | Executive | Purchase | 500,000 | $0.02 | $10.0K | |
| Jun 29, 2023 | Trieu Vuong | Executive | Purchase | 425,000 | $0.02 | $8.5K | |
| Jun 28, 2023 | Trieu Vuong | Executive | Purchase | 75,000 | $0.03 | $2.3K | |
| Jun 16, 2023 | Trieu Vuong | Executive | Purchase | 100,000 | $0.03 | $3.0K | |
| Jun 14, 2023 | Trieu Vuong | Executive | Purchase | 400,000 | $0.03 | $12.0K | |
| May 26, 2023 | Trieu Vuong | Executive | Purchase | 126,888 | $0.03 | $3.8K | |
| May 2, 2023 | Trieu Vuong | Executive | Purchase | 100,000 | $0.05 | $5.0K | |
| Dec 6, 2022 | Trieu Vuong | Executive | Purchase | 120,000 | $0.05 | $6.0K | |
| Nov 22, 2022 | Trieu Vuong | Executive | Purchase | 70,000 | $0.08 | $5.6K | |
| Sep 26, 2022 | Trieu Vuong | Executive | Purchase | 20,000 | $0.07 | $1.4K | |
| Aug 25, 2022 | Trieu Vuong | Executive | Purchase | 80,000 | $0.08 | $6.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 14 | $65.9K | 100.0% |
Award(A) | 4 | $0 | 0.0% |
Conversion(C) | 6 | $0 | 0.0% |
Insiders at Oncotelic Therapeutics, Inc. are accumulating shares at an accelerated pace. With 5 insiders making 24 transactions totaling $65.9K in purchases versus $0 in sales, the net buying activity of $65.9K signals strong executive confidence. Vuong Trieu (Executive) leads the buying activity with $65.9K in transactions across all time.